1.A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab.
Jongseok PARK ; Hoyoung LEE ; Young Kook KIM ; Jeong Don CHAE ; Hyun Joo LEE
Korean Journal of Ophthalmology 2011;25(5):362-365
We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, presented with a clinical picture of elevated intraocular pressure and ocular pain. Upon slit-lamp examination, we found a ciliary injection and a pseudohypopyon of polychromatic crystals. Gonioscopic examination revealed a large amount of crystals deposited on the trabecular meshwork and mild rubeosis iridis, but the neovascularization of the angle could not be clearly confirmed due to the presence of so many crystals. Pars plana vitrectomy was performed to remove clusters of crystals and bevacizumab was injected intravitreally to treat iris neovascularization. Aqueous aspirate was examined by light microscopy and the typical highly refringent cholesterol crystals were identified. Intraocular pressure returned to a normal level after the bevacizumab injection, although severe cholesterosis was still evident in the anterior chamber. To our knowledge, this would be the first Korean case of cholesterosis bulbi combined with chronic retinal detachment and presumed neovascular glaucoma, which was treated by pars plana vitrectomy and intravitreal bevacizumab injection.
Adult
;
Angiogenesis Inhibitors/therapeutic use
;
Anterior Chamber/*metabolism
;
Antibodies, Monoclonal, Humanized/*therapeutic use
;
*Cholesterol
;
Eye Diseases/complications/metabolism
;
Follow-Up Studies
;
Glaucoma/surgery
;
Glaucoma, Neovascular/drug therapy/*etiology/surgery
;
Humans
;
Intraocular Pressure
;
Male
;
Vitrectomy/*methods
2.Forty-one cases of secondary optic atrophy after anti-glaucoma surgery treated with combined therapy of acupuncture and medication.
Chinese Acupuncture & Moxibustion 2012;32(8):689-690
Acupuncture Therapy
;
Adult
;
Aged
;
Combined Modality Therapy
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Glaucoma
;
complications
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Optic Atrophy
;
drug therapy
;
etiology
;
physiopathology
;
therapy
;
Vision, Ocular
3.Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series.
Jin Young CHOI ; Jaewan CHOI ; Yeon Deok KIM
Korean Journal of Ophthalmology 2010;24(1):47-52
This prospective observational case series study included 6 eyes of 6 consecutive glaucomatous patients. Each patient underwent trabeculectomy with mitomycin C, and received a 1.25 mg of subconjunctival bevacizumab injection at completion of the trabeculectomy. Study eyes included two with neovascular glaucoma, three with uveitic glaucoma, and one with secondary glaucoma following vitrectomy. All eyes had undergone failed glaucoma laser/surgical treatment or an intraocular surgical procedure. Intraocular pressure (IOP) at the following postoperative visits: preoperative, 1 week, 1 month, 2 months, 3 months, and 6 months, was measured. We also evaluated postoperative bleb findings and complications. IOP measured at each visit was 37.5+/-14.4 mmHg, 6.2+/-3.4 mmHg, 8.3+/-7.2 mmHg, 12.0+/-4.4 mmHg, 10.8+/-3.1 mmHg, and 12.2+/-3.3 mmHg, respectively, for each visit. All eyes had functioning blebs with normal IOP at postoperative 6 months with no additional IOP-lowering medication.
Adult
;
Aged
;
Angiogenesis Inhibitors/*administration & dosage
;
Antibodies, Monoclonal/*administration & dosage
;
Conjunctiva
;
Female
;
Glaucoma/*drug therapy/etiology/*surgery
;
Glaucoma, Neovascular/drug therapy/surgery
;
Humans
;
Injections, Intraocular
;
Male
;
Middle Aged
;
Prospective Studies
;
Trabeculectomy/*methods
;
Uveitis/complications
;
Vascular Endothelial Growth Factor A/*antagonists & inhibitors
;
Vitrectomy/adverse effects
4.Decompression Retinopathy after Trabeculectomy.
Korean Journal of Ophthalmology 2005;19(2):128-131
PURPOSE: To present a case of a unilateral diffuse retinal hemorrhage in a 15-year-old girl, who underwent bilateral trabeculectomy for steroid induced glaucoma. METHODS: Despite the maximally tolerable medical treatment, IOP in the right eye remained above 50 mmHg for four months, and was simultaneously elevated in the left eye. So we performed bilateral trabeculectomy. RESULTS: On the first postoperative day, diffuse retinal hemorrhages were observed in the right eye; however, no retinal hemorrhage was found in the left eye. The hemorrhages resolved completely without consequences two months later. CONCLUSIONS: In the case of high IOP for a long period, sudden lowering of IOP may acutely increase the blood flow and consequently rupture multiple retinal capillaries because of altered autoregulatory function. Special care is therefore needed to prevent an abrupt fall in IOP before, during, and after surgery, especially when IOP has been highly elevated for an extended period.
Administration, Topical
;
Adolescent
;
Female
;
Fluorescein Angiography
;
Fundus Oculi
;
Glaucoma/chemically induced/*surgery
;
Humans
;
Retinal Hemorrhage/diagnosis/*etiology/pathology
;
Steroids/administration & dosage/adverse effects/therapeutic use
;
Trabeculectomy/*adverse effects
;
Uveitis/drug therapy